Partner Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-20,100
Closed -$1.08M 96
2016
Q3
$1.08M Buy
+20,100
New +$1.29M 1.61% 23
2015
Q1
Sell
-42,900
Closed -$5K 88
2014
Q4
$5K Sell
42,900
-6,400
-13% -$361K ﹤0.01% 85
2014
Q3
$29K Buy
+49,300
New +$2.46M 0.01% 60

Other funds holding BMY

Partner Investment Management's BMY Position: Q2 2018 in Review

Partner Investment Management sold out of Bristol-Myers Squibb (BMY) in Q2 2018, closing a stake of 55,719 shares — an estimated $3.52M sold.

Partner Investment Management first reported a position in BMY in Q4 2013 and held it in 9 quarters. The position peaked at $39.2M in Q1 2014. 1,692 funds tracked by Wall St. Rank hold BMY as of Q2 2018.

  • Partner Investment Management reported no remaining Bristol-Myers Squibb position as of Q2 2018 after selling out during the quarter.
  • Partner Investment Management sold 55,719 Bristol-Myers Squibb shares in Q2 2018, an estimated $3.52M.
  • Partner Investment Management first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 9 quarters.
  • Partner Investment Management's Bristol-Myers Squibb position peaked at $39.2M in Q1 2014.
  • 1,692 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2018.

Based on Partner Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.